| Officer | Age | In this role | Joined | Pay | Source |
|---|---|---|---|---|---|
|
Kelvin Cooper
Also a director
Chief Executive Officer, SVP Research & Development
|
71 | Not stated | 2021 | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased three unsecured promissory notes (12% interest) issued in February to April 2026 to fund short-term working capital.
Short-term promissory note issued to the Company, later amended to conform to the $1.25 million convertible note financing.
Promissory note issued to the Company, later amended to conform to the convertible note financing.
Participated in the $1.5 million convertible notes.
Participated in the $1.5 million convertible notes.
Participated in the $1.5 million convertible notes.
Participated in the $1.5 million convertible notes.
Notes payable to Lindesfarne converted into 56,307 shares of common stock and accrued interest was forgiven, resulting in a capital contribution.
Loading...
